STAAR Surgical logo

STAAR Surgical

STAA | NASDAQ
Chart Builder DCF Calculator
$20.32
-$0.50 (-2.40%)
At close: Sep 21, 2026, 4:00 PM ET
$20.44
+$0.12 (+0.59%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$1.01B
Enterprise Value
$866.15M
Beta
1.22
Average Volume
901.68K
Shares Outstanding (Diluted)
51.5M
Shares Change YoY
4%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US8523123052

Price Performance

Price Change 1M
-12.8%
Price Change 3M
-28.4%
Price Change 6M
5.9%
Price Change YTD
-13.9%
Price Change 1Y
-24.4%
Price Change 3Y
-48.4%
Price Change 5Y
-85.8%
1M CAGR (ann.)
-16.1%
1Y CAGR (ann.)
-25.2%
5Y CAGR (ann.)
-31.9%
All-Time CAGR
4.7%

Valuation

PE Ratio
254.00
Forward PE
72.21
PEG Ratio
0.74
Forward PEG
2.82
PS Ratio
2.98
Forward PS
3.00
PB Ratio
2.77
P/FCF Ratio
-149.90
P/Adj. FCF Ratio
-28.99
P/OCF Ratio
-338.67
EV/Sales
2.55
EV/EBIT
37.61
EV/EBITDA
27.03
EV/FCF
-128.34
Earnings Yield
0.4%
FCF Yield
-0.7%
Adj. FCF Yield
-3.5%

Financial Health

Net Cash
$181.49M
Total Debt
$35.94M
Cash & Short-Term Investments
$181.49M
Total Assets
$475.21M
Current Ratio
4.66
Quick Ratio
4.03
Debt / Equity Ratio
0.10
Debt / EBITDA
1.12
Debt / FCF
-5.33
OCF / Debt
-0.09
Interest Coverage
0.00
Altman Z-Score
6.68
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
76.2%
Operating Profit Margin
10.3%
EBITDA Margin
9.4%
Net Profit Margin
1.1%
FCF Margin
-2.0%
Adj. FCF Margin
-10.3%
SBC / Revenue
8.3%
SBC Impact (per share)
-417.2%

Returns

Return on Assets
0.8%
Return on Equity
1.1%
Return on Invested Capital
1.9%
Return on Capital Employed
8.7%
Return on Tangible Assets
0.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
3.5%
Revenue CAGR 5Y
10.5%
Revenue CAGR 10Y
15.6%
EPS CAGR 3Y
-45.7%
EPS CAGR 5Y
-28.2%
EPS CAGR 10Y
-174.6%
FCF CAGR 3Y
-82.4%
FCF CAGR 5Y
-377.1%
FCF CAGR 10Y
-67.6%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
16
EPS Growth Next 3Y
102.1%
Revenue Growth Next 3Y
4.8%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
$0.20
EPS Growth Est (next Q)
-56.5%
Revenue Est (next Q)
$79.1M
Revenue Growth Est (next Q)
-16.5%

Fair Value Estimates

Graham Number
$3.61
Graham Upside
-82.2%
Lynch Fair Value
$0.40
Lynch Upside
-98.0%
Price Target
$31.50
Price Target Upside
55.0%

Cash Flow

Operating Cash Flow
$-3.25M
Free Cash Flow
$-6.75M
Adj. Free Cash Flow
$-34.9M
FCF Per Share
-$0.13
OCF Per Share
-$0.06
OCF/S Ratio
-1.0%

Income Statement

Revenue
$339.59M
Gross Profit
$258.87M
Operating Income
$35.06M
EBITDA
$32.05M
Net Income
$3.84M
EPS (Diluted)
$0.08
Revenue / Employee
$368.72K
Profit / Employee
$4.17K
Employees
921

© 2026 bestshares.com. All rights reserved.